CCMB scientists moot new drug targets on cells

Their study shows a sensor region on human serotonin1A receptor can detect cholesterol

July 27, 2021 07:09 pm | Updated August 04, 2021 12:05 am IST - HYDERABAD

The team led by Amitabha Chattopadhyay collaborated with Jana Selent’s group from Pompeu Fabra University Hospital del Mar Medical Research Institute in Barcelona, Spain, for the study.

The team led by Amitabha Chattopadhyay collaborated with Jana Selent’s group from Pompeu Fabra University Hospital del Mar Medical Research Institute in Barcelona, Spain, for the study.

Cells communicate with each other via ‘receptor proteins’ on the cell membranes which are targets for drugs to alter functioning and physiology. However, the latest study from Amitabha Chattopadhyay’s lab at CSIR-Centre for Cellular and Molecular Biology (CCMB) makes a case for designing new drugs to focus on the lipid environment surrounding these receptor proteins.

The lab had earlier found that the serotonin receptors are sensitive to cholesterol surrounding them.

In the new study published in ‘Science Advances’, they report a sensor region on ‘human serotonin1A’ receptor can detect cholesterol, specifically a region called ‘CRAC motifs’, which are believed to interact with cholesterol, said an official release on Tuesday.

Researchers replaced the specific amino acids in these CRAC motifs and came across a particular amino acid responsible for cholesterol-sensitive function. They collaborated with Jana Selent’s group from Pompeu Fabra University Hospital del Mar Medical Research Institute in Barcelona, Spain, to visualise the protein-cholesterol interaction via computer-aided molecular dynamics simulations.

This helped them predict how the specific amino acid on CRAC motif enables the receptor proteins to sense changes in cholesterol levels by controlling molecular motion in certain regions.

“Cholesterol levels change in our cells with age and in disease conditions. We believe our work will help in developing better drugs that keep in mind not just the receptor proteins as the drug target, but also the lipid environment in which it is present,” said Mr Chattopadhyay.

“Our expertise in structural biology at CCMB is key towards physical understanding of cells and their functions. This not only adds to the detailed view of living cells but also have immense potential in therapeutics development”, said CCMB director Vinay Nandicoori.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.